News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling
Nicholas DeVito/LinkedIn
Apr 22, 2025, 14:05

Nicholas DeVito: Duke’s first-line immunotherapy trial for advanced/metastatic CRC is still enrolling

Nicholas DeVito, Assistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared a post on LinkedIn:

“Our first-line immunotherapy (botensilimab/balstilimab) trial for advanced/metastatic colorectal cancer without liver, bone, or brain metastasis is still enrolling!

This trial is supported by Gateway for Cancer Research, Duke CRUSH CRC, and patient philanthropy.

Learn more about the BBOpCo trial here.”

Balstilimab BBOpCo botensilimab cancer Duke CRUSH CRC Duke University fight against cancer Gateway for Cancer Research Global fight against cancer immunotherapy mCRC MedOnc Nicholas DeVito OncoDaily Oncology
Special Coverage
New Paper Alert
Aug 14, 2025, 00:38
Survival Benefit of High TMB and BRAF Mutation in Advanced Melanoma on Adjuvant Anti–PD-1
Insight
Aug 13, 2025, 21:09
Elisa Agostinetto: Patients’ and Physicians’ Perspectives on Brain Imaging Screening in Metastatic Breast Cancer
Insight
Aug 13, 2025, 21:09
Amir Manbachi: Fighting Glioblastoma with Sound Waves
Voices
Aug 13, 2025, 20:52
Chiara Corti: Ranking Oncologists in Social Media - What Could Go Wrong?
Insight
Aug 13, 2025, 20:36
Talha Badar: Brief Thread on Clonal Hematopoiesis
Voices
Aug 13, 2025, 20:35
Ethical, Legal, and Governance Challenges of Digitalising Oncology Care - European Health Management Association
Voices
Aug 13, 2025, 20:22
Stephen V Liu: Cataloging Success - Repotrectinib's Efficacy in a ROS1 NSCLC Resistance Case
Opinion
Aug 13, 2025, 20:15
Tom Powles: Opening a New Area for Cis-Ineligible MIBC
Voices
Aug 13, 2025, 19:46
Mario Balsa: ESMO Guidelines for Localized Rectal Cancer Are Here
Science
Aug 13, 2025, 19:37
Patterns of HER2 Expression in Metastatic Prostate and Urothelial Cancers
Science
Aug 13, 2025, 19:21
Naveen Pemmaraju: Prognostic Impact of NPM1 Co-Mutation in FLT3-Mutated AML
Voices
Aug 13, 2025, 19:12
Narjust Florez: Are Women More Affected by Lung Cancer Surgery?